Les différents traitements hormonaux substitutifs (THS) de la ménopause présentent des risques différents, conclut cette analyse menée à l’Université d'Uppsala de 7 traitements hormonaux différents. L ...
Cette équipe de la Cleveland Clinic (Ohio) confirme le lien déjà suggéré entre les substituts du sucre et un risque accru de crise cardiaque et d'accident vasculaire cérébral (AVC). La recherche, ...
Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced ...
About Recce Pharmaceuticals Ltd Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health problems of ...
Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic disorders. On track to report topline data ...
A live webcast of the presentation will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with ...
On Monday, December 2, at 11:30 a.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, and Jane Huang, M.D., President and Chief Medical Officer, will participate in a fireside chat.
Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today ...
Piper Sandler 36 th Annual Healthcare Conference The live and archived webcast of the presentations can be accessed in the Investors section of the Company’s website here.